| Sanofi-Aventis (Suisse) SA - Targocid 400 mg, poudre et solvant pour solution injectable/pour perfusion ou solution buvable |
| 49339 | | 03 | | Targocid 400 mg | | poudre et solvant pour solution injectable/pour perfusion ou solution buvable | | J01XA02 | | Teicoplanin | | 11.09.1990 | | |
|
| Composition |
| Praeparatio cryodesiccata: teicoplaninum 400 mg, natrii chloridum, natrii hydroxidum, pro vitro corresp. natrium 9.77 mg.
Solvens: aqua ad iniectabile 3 ml. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | poudre et solvant pour solution injectable/pour perfusion ou solution buvable | | | | | | | | Active Agent | Dose |
|---|
| Teicoplanine | 400 mg |
| | BAG: Active Agent | Dose |
|---|
| Teicoplanine | 400 mg |
| | | | Inactive agents |
|---|
| Sodium Chloride | | Sodium Hydroxide |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
